-
1.
公开(公告)号:US07943654B2
公开(公告)日:2011-05-17
申请号:US11988528
申请日:2006-07-10
IPC分类号: A01N43/56 , A01N43/06 , A61K31/415 , A61K31/38 , C07D487/02 , C07D231/54 , C07D333/00
CPC分类号: C07D495/04
摘要: There are provided thieno[2,3-c]pyrazole derivatives of formula (I), wherein A is an aryl or heteroaryl ring, on which the substituent-NHZR5 is at the ortho position to the CONH linker; R1 and R2 are the same or different and, independently from each other, represent a hydrogen atom or an organic group; R4 is a hydrogen or halogen atom or an organic group; Z is direct bond, >C═O, or —C(═O)NH—; R5 is hydrogen or an organic group; or isomers, tautomers, carriers, metabolites, prodrugs, and pharamaceutically acceptable salts thereof. A process for their preparation and pharamaceutical compositions comprising them are also disclosed; the compounds of the invention may be useful, in theraphy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
摘要翻译: 提供式(I)的噻吩并[2,3-c]吡唑衍生物,其中A是芳基或杂芳基环,取代基-NHZR5在其上与CONH连接体的邻位; R1和R2相同或不同,彼此独立地表示氢原子或有机基团; R4是氢或卤素原子或有机基团; Z是直接键合,> C = O或-C(= O)NH-; R5是氢或有机基团; 或异构体,互变异构体,载体,代谢物,前药和药物上可接受的盐。 还公开了其制备方法和包含它们的药用组合物; 本发明的化合物在治疗与失调的蛋白激酶活性相关的疾病(例如癌症)中可能是有用的。